Janet Xiao will speak at the summit on Life Sciences IP Due Diligence, a Life Sciences industry think tank for assessing, valuing, and commercializing IP Assets, discussing IP due diligence considerations for global deals to mitigate international legal risk. She is joined by Yu-Ming Dammann, Associate General Counsel, at Gilead Sciences. They will address:
- Identifying due diligence landmines that U.S. practitioners should avoid when doing deals globally
- Assessing how the new CFIUS regulations are increasing government scrutiny over foreign investment in U.S. biotech companies, and the impact this has on due diligence relating to deals with such companies
- Evaluating foreign IP assets based upon the specific rules for their jurisdiction
09 Nov 2020 07:15 p.m. - 08:00 p.m.
Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
© Morrison & Foerster LLP. All rights reserved
